tiprankstipranks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
Want to see DRUG full AI Analyst Report?

Bright Minds Biosciences (DRUG) Technical Analysis

281 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is 3.45, suggesting Bright Minds Biosciences is a Sell.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 81.37, while Bright Minds Biosciences’s (DRUG) share price is $89.9, making it a Buy.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 79.20, while Bright Minds Biosciences’s (DRUG) share price is $89.9, making it a Buy.

Bright Minds Biosciences (DRUG) Pivot Points

May 12, 2026, 01:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
83.06
84.53
86.59
88.06
90.12
91.59
93.65
Fibonacci
84.53
85.88
86.71
88.06
89.41
90.24
91.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

May 12, 2026, 01:20 AM
Period
Simple
Exponential
MA5
88.50Buy
88.04Buy
MA10
84.66Buy
84.93Buy
MA20
78.25Buy
81.37Buy
MA50
78.71Buy
79.20Buy
MA100
80.01Buy
75.51Buy
MA200
63.17Buy
61.83Buy
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 84.93, while Bright Minds Biosciences’s (DRUG) share price is $89.9, making it a Buy.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 75.51, while Bright Minds Biosciences’s (DRUG) share price is $89.9, making it a Buy.
Bright Minds Biosciences’s (DRUG) stock price is $89.9 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 78.71, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $89.9 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 80.01, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $89.9 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 63.17, creating a Buy signal.

Bright Minds Biosciences (DRUG) Technical Indicators

May 12, 2026, 01:20 AM
Name
Value
Implied Action
RSI (14)
67.43
Neutral
STOCH (9,6)
91.98
Sell
STOCHRSI (14)
93.45
Sell
MACD (12,26)
3.45
Sell
ADX (14)
22.01
Neutral
Williams %R
-9.51
Sell
CCI (14)
128.13
Sell
ATR (14)
4.84
-
Ultimate Oscillator
63.96
Neutral
ROC
28.25
Buy
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 67.43, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 22.01, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is 128.13, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is 28.25, creating a Buy signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Buy.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 67.43, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is 3.45, which suggests DRUG is a Sell.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 88.50, which suggests DRUG is a Buy.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 78.25, which suggests DRUG is a Buy.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 78.71, which suggests DRUG is a Buy.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 63.17, which suggests DRUG is a Buy.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -9.51, which suggests DRUG is a Sell.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is 128.13, which suggests DRUG is a Sell.